Use and timing of radiotherapy in high-risk prostate cancer

被引：2
|
作者：
Ward, JF [1 ]
Blute, ML
机构：
[1] USN, Dept Urol Oncol, Med Ctr, Portsmouth, VA 23708 USA
[2] Mayo Clin, Dept Urol, Rochester, MN USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 291卷 / 23期
关键词：
D O I：
10.1001/jama.291.23.2817-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2817 / 2817
页数：1
相关论文
共 50 条
  • [31] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Saad, Akram
    Goldstein, Jeffrey
    Lawrence, Yaacov R.
    Spieler, Benjamin
    Leibowitz-Amit, Raya
    Berger, Raanan
    Davidson, Tima
    Urban, Damien
    Tsang, Lev
    Alezra, Dror
    Weiss, Ilana
    Symon, Zvi
    RADIATION ONCOLOGY, 2017, 12
  • [32] Preoperative radiotherapy for high-risk prostate cancer (PORT-PC) trial
    Nagar, Himanshu
    Formenti, Silvia
    Scherr, Douglas
    Hu, Jim C.
    Schlegel, Peter
    Kang, Josephine
    Robinson, Brian D.
    Khani, Francesca
    Nanus, David M.
    Tagawa, Scott T.
    Molina, Ana M.
    Faltas, Bishoy Morris
    Margolis, Daniel
    Barbieri, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [33] Early. Salvage vs Adjuvant Radiotherapy for High-Risk Prostate Cancer
    Tendulkar, Rahul
    Wu, Wayland J.
    Potters, Louis
    ONCOLOGY-NEW YORK, 2017, 31 (10): : 750 - 754
  • [34] The Largest Transcriptomic Resource for Radiotherapy-treated High-risk Prostate Cancer
    Thiruthaneeswaran, N.
    Bibby, B.
    Pereira, R. R.
    Bristow, R. G.
    Choudhury, A.
    West, C. M. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S25 - S25
  • [35] DOSIMETRIC COMPARISON AND TOXICITY ANALYSIS OF STEREOTACTIC RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER
    Callan, Laura
    Bauman, Glenn
    Chen, Jeff
    Lock, Michael
    Sexton, Tracy
    D'Souza, David
    Rodrigues, George
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S17 - S18
  • [36] New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer
    Tharmalingam, Hannah
    Choudhury, Ananya
    Van Herk, Marcel
    McWilliam, Alan
    Hoskin, Peter J.
    NATURE REVIEWS UROLOGY, 2019, 16 (09) : 523 - 538
  • [37] Hypofractionated versus conventional radiotherapy in intermediate- to high-risk prostate cancer
    Guo, W.
    Gao, X. S.
    Gu, X. B.
    Ma, M. W.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S716 - S716
  • [38] Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer
    Garcia Hernandez, Trinitat
    Vicedo Gonzalez, Aurora
    Pastor Peidro, Jorge
    Rosella Ferrando, Juan V.
    Brualla Gonzalez, Luis
    Granero Cabanero, Domingo
    Lopez Torrecilla, Jose
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (05) : 265 - 271
  • [39] New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer
    Hannah Tharmalingam
    Ananya Choudhury
    Marcel Van Herk
    Alan McWilliam
    Peter J. Hoskin
    Nature Reviews Urology, 2019, 16 : 523 - 538
  • [40] Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer
    Ohaegbulam, Kim C.
    Post, Carl M.
    Farris, Paige E.
    Garzotto, Mark
    Beer, Tomasz M.
    Hung, Arthur
    Williamson, Casey W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (02): : 75 - 82
12345